Viatris Business Summary

Viatris Inc. (VTRS) operates a diversified global healthcare model, generating revenue through the sale of branded, generic, and complex generic pharmaceuticals, as well as biosimilars and active pharmaceutical ingredients (APIs). The company’s business is organized into four primary geographic segments: Developed Markets, Emerging Markets, JANZ (Japan, Australia, and New Zealand), and Greater China. Following a comprehensive strategic restructuring completed in late 2025, Viatris has pivoted toward high-margin specialty pillars, specifically focusing on its Eye Care Division and other innovative therapies, while maintaining a massive portfolio of over 1,400 molecules. Key revenue drivers include established brands like Lipitor and Norvasc, alongside specialty assets such as Tyrvaya and Ryzumvi. Direct competitors include Teva Pharmaceutical Industries, Sandoz Group AG, Pfizer, and Bausch + Lomb; Viatris occupies a unique market position as a specialty-focused powerhouse that leverages a massive global commercial infrastructure to bridge the gap between traditional generics and innovative medicine. Formed in November 2020 through the merger of Mylan N.V. and Pfizer’s Upjohn division, Viatris is currently led by CEO Scott A. Smith, a seasoned executive with over 35 years of experience, including previous roles as President and COO of Celgene Corp. The financial organization is headed by CFO Doretta (Theodora) Mistras, who brought nearly two decades of healthcare investment banking expertise from Goldman Sachs and Citigroup when she joined in 2024. Other key executives include Chief R&D Officer Philippe Martin and Chief Commercial Officer Corinne Le Goff. The Board of Directors is chaired by Melina Higgins, a former partner at Goldman Sachs, and features a high-pedigree roster including Frank D’Amelio (former Pfizer CFO) and Michael Severino (former AbbVie Vice Chairman). The company is backed by a strong institutional investor base, including major asset managers like Vanguard and BlackRock, as it executes its long-term strategy for sustainable revenue growth and capital return.